HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jung Han Yoon Park Selected Research

3,3',4,5'-tetrahydroxystilbene

5/2022Piceatannol, a metabolite of resveratrol, attenuates atopic dermatitis by targeting Janus kinase 1.
11/2015Inhibition of tumor progression by oral piceatannol in mouse 4T1 mammary cancer is associated with decreased angiogenesis and macrophage infiltration.
3/2012Piceatannol inhibits migration and invasion of prostate cancer cells: possible mediation by decreased interleukin-6 signaling.
11/2009Piceatannol, a natural stilbene from grapes, induces G1 cell cycle arrest in androgen-insensitive DU145 human prostate cancer cells via the inhibition of CDK activity.
10/2009The grape component piceatannol induces apoptosis in DU145 human prostate cancer cells via the activation of extrinsic and intrinsic pathways.
12/2008Piceatannol, a stilbene present in grapes, attenuates dextran sulfate sodium-induced colitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jung Han Yoon Park Research Topics

Disease

51Neoplasms (Cancer)
09/2022 - 08/2003
25Colonic Neoplasms (Colon Cancer)
09/2014 - 07/2002
17Inflammation (Inflammations)
09/2020 - 01/2008
17Prostatic Neoplasms (Prostate Cancer)
06/2016 - 01/2006
15Obesity
02/2024 - 06/2012
11Neoplasm Metastasis (Metastasis)
05/2017 - 12/2009
8Carcinoma (Carcinomatosis)
06/2016 - 01/2006
8Carcinogenesis
05/2015 - 07/2002
7Breast Neoplasms (Breast Cancer)
06/2016 - 01/2006
6Hypertension (High Blood Pressure)
06/2016 - 12/2008
6Edema (Dropsy)
11/2014 - 12/2009
4Alzheimer Disease (Alzheimer's Disease)
05/2023 - 01/2017
4Melanoma (Melanoma, Malignant)
05/2017 - 12/2013
4Hypoxia (Hypoxemia)
05/2017 - 05/2012
4Body Weight (Weight, Body)
11/2015 - 01/2006
3Atherosclerosis
02/2018 - 08/2002
3Adenocarcinoma
01/2016 - 02/2011
3Colitis
01/2015 - 12/2008
3Hepatocellular Carcinoma (Hepatoma)
05/2013 - 11/2008
2Atopic Dermatitis (Atopic Eczema)
05/2022 - 02/2020
2Hypersensitivity (Allergy)
05/2022 - 05/2013
2Memory Disorders (Memory Loss)
01/2020 - 01/2018
2Lymphatic Metastasis
05/2017 - 09/2015
2Hypokalemia
06/2016 - 12/2013
2Leukemia
01/2015 - 12/2007

Drug/Important Bio-Agent (IBA)

22Proteins (Proteins, Gene)FDA Link
05/2023 - 12/2005
11CytokinesIBA
04/2015 - 11/2008
9Conjugated Linoleic AcidsIBA
02/2010 - 07/2002
7LipidsIBA
01/2019 - 01/2015
7HexanesIBA
06/2016 - 12/2008
6AntioxidantsIBA
09/2022 - 08/2002
63,3',4,5'-tetrahydroxystilbeneIBA
05/2022 - 12/2008
63,3'-diindolylmethane (diindolylmethane)IBA
10/2017 - 05/2009
6Ethanol (Ethyl Alcohol)IBA
06/2016 - 12/2008
6Glycyrrhizic Acid (Glycyrrhizin)IBA
06/2016 - 12/2008
6isoliquiritigenin (GU 17)IBA
09/2009 - 01/2006
5EnzymesIBA
01/2019 - 01/2007
5Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA
02/2018 - 05/2013
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2017 - 11/2011
5Messenger RNA (mRNA)IBA
10/2016 - 01/2013
5isoangustone AIBA
06/2016 - 09/2010
5LipopolysaccharidesIBA
11/2014 - 01/2008
5IGF Type 1 Receptor (IGF 1 Receptor)IBA
09/2014 - 08/2003
51,2-Dimethylhydrazine (1,2 Dimethylhydrazine)IBA
04/2006 - 07/2002
4Caspase 3 (Caspase-3)IBA
05/2023 - 11/2011
4PhytochemicalsIBA
02/2023 - 08/2009
4GenisteinIBA
09/2020 - 01/2005
4benzyl isothiocyanateIBA
01/2016 - 11/2011
4DNA (Deoxyribonucleic Acid)IBA
01/2016 - 08/2003
4Drinking WaterIBA
01/2015 - 12/2008
4Insulin-Like PeptidesIBA
12/2014 - 02/2005
3isothiocyanic acidIBA
12/2023 - 02/2009
3sulforaphaneIBA
12/2023 - 01/2017
3ResveratrolIBA
05/2022 - 05/2013
3IsoflavonesIBA
02/2020 - 03/2017
3Conditioned Culture MediaIBA
04/2015 - 01/2011
3AntigensIBA
01/2015 - 01/2012
3Dextran SulfateIBA
01/2015 - 12/2008
3kaempferolIBA
09/2014 - 09/2013
3Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
09/2014 - 05/2012
3FlavonoidsIBA
12/2013 - 01/2006
3Anticarcinogenic AgentsIBA
09/2013 - 02/2010
3Cyclin-Dependent Kinases (cdk Proteins)IBA
06/2013 - 12/2005
3AdipokinesIBA
02/2013 - 07/2011
3Hemoglobins (Hemoglobin)IBA
11/2012 - 10/2008
3Insulin-Like Growth Factor II (Somatomedin A)IBA
01/2012 - 01/2003
3Proliferating Cell Nuclear Antigen (PCNA)IBA
11/2011 - 08/2010
3Death Domain ReceptorsIBA
02/2011 - 10/2009
3AzoxymethaneIBA
08/2010 - 01/2006
3AndrogensIBA
11/2009 - 12/2008
3Cisplatin (Platino)FDA LinkGeneric
07/2008 - 11/2007
2sulphorapheneIBA
02/2024 - 12/2023
2Brain-Derived Neurotrophic Factor (BDNF)IBA
05/2023 - 01/2017
2orobolIBA
09/2020 - 01/2019
2Interleukin-6 (Interleukin 6)IBA
09/2020 - 03/2012
2Amyloid (Amyloid Fibrils)IBA
01/2020 - 01/2018
2Phosphotransferases (Kinase)IBA
02/2018 - 01/2005
2Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA
02/2018 - 06/2017
2Heat-Shock Proteins (Heat-Shock Protein)IBA
01/2018 - 01/2006
2proanthocyanidinIBA
11/2017 - 06/2017
2Biomarkers (Surrogate Marker)IBA
06/2017 - 11/2014
2Vascular Endothelial Growth Factor CIBA
05/2017 - 06/2016
2Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
01/2017 - 01/2013
2Matrix Metalloproteinases (MMPs)IBA
10/2016 - 12/2009
2licoricidinIBA
06/2016 - 11/2010
2glucotropeolinIBA
01/2016 - 11/2011
29,10-Dimethyl-1,2-benzanthraceneIBA
12/2015 - 05/2015
2Insulin ReceptorIBA
12/2015 - 12/2014
2Transcription Factors (Transcription Factor)IBA
11/2015 - 11/2012
2Cyclin D1IBA
11/2015 - 11/2012
2Cyclin AIBA
11/2015 - 11/2012
2caryophylleneIBA
09/2015 - 01/2015
2Macrophage Colony-Stimulating FactorIBA
01/2015 - 01/2015
2ChemokinesIBA
01/2015 - 09/2012
2LeptinIBA
12/2014 - 07/2011
2salvinIBA
12/2014 - 07/2014
2Insulin (Novolin)FDA Link
12/2014 - 07/2011

Therapy/Procedure

9Therapeutics
02/2020 - 11/2007
4Oral Administration
11/2015 - 12/2009
3Drug Therapy (Chemotherapy)
12/2008 - 03/2008